Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis Patients

Clinical trial NCT02246920 · TERMINATED

Trial details

NCT number: NCT02246920
Sponsor: Teva Pharmaceuticals USA
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis

Start date: 2014-03-01
Primary completion: 2014-07-14
Enrollment: 1474

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.